Endometrial stromal sarcoma is a rare type of cancer that develops in the connective tissue of the uterus. While it represents only a small fraction of uterine cancers, understanding how to manage it is essential for those affected. Treatment approaches depend on the stage of the disease, whether it has spread, and the characteristics of the cancer cells. From surgery to targeted medicines, doctors now have several tools to help patients live longer and maintain a better quality of life.

Understanding Your Treatment Options

When someone is diagnosed with endometrial stromal sarcoma, the first question is often about what happens next. The main goal of treatment is to remove the cancer, prevent it from coming back, and help manage any symptoms. For those whose cancer has already spread, treatment focuses on controlling the disease and maintaining quality of life for as long as possible.^[1]

Treatment decisions are never one-size-fits-all. Your medical team will consider multiple factors before recommending a plan. These include whether the cancer is confined to the uterus or has spread to nearby or distant areas. The grade of the cancer matters too. Low-grade endometrial stromal sarcoma means the cancer cells look somewhat similar to normal cells and tend to grow slowly. High-grade endometrial stromal sarcoma, on the other hand, indicates cancer cells that look very different from normal cells and may grow and spread more quickly.^[2]

Your age, overall health, and personal preferences also play a role. For example, younger women who have not completed their families may have different concerns about treatment than women past menopause. Some treatments can affect fertility, so these discussions happen early in the planning process.^[6]

The care of patients with endometrial stromal sarcoma typically involves a team of specialists. This group might include gynecologic oncologists, medical oncologists, radiation oncologists, and pathologists. Each brings expertise that helps create the most effective treatment plan. This multidisciplinary approach ensures that all aspects of the disease are considered before any major decisions are made.^[12]

Standard Treatment: Surgery as the Foundation

Surgery is the most important treatment for endometrial stromal sarcoma. In most cases, the goal is to remove the uterus entirely. This operation, called a total hysterectomy, is the standard approach for patients whose cancer has not spread beyond the uterus. During this procedure, the surgeon removes the uterus and often the cervix as well.^[1]

In addition to removing the uterus, surgeons often remove both ovaries and fallopian tubes. This procedure is called bilateral salpingo-oophorectomy. The reason for removing the ovaries is that endometrial stromal sarcoma cells can respond to hormones like estrogen and progesterone. By removing the ovaries, doctors reduce hormone levels in the body, which may help prevent the cancer from returning.^[6]

However, the decision to remove the ovaries is not always straightforward, especially in younger women who have not reached menopause. Removing the ovaries causes immediate menopause, which can bring symptoms like hot flashes, mood changes, and long-term effects on bone health. In carefully selected cases of early-stage, low-grade disease, doctors may discuss preserving the ovaries. This decision is made individually, weighing the risk of recurrence against the impact on quality of life.^[6]

During surgery, the surgeon also examines the surrounding areas. If the cancer has spread to nearby tissues or lymph nodes, those may be removed as well. However, the role of routine lymphadenectomy, or removal of lymph nodes, in endometrial stromal sarcoma remains controversial. Some experts believe it helps determine the extent of disease, while others question whether it improves survival. Each case is evaluated individually.^[6]

Sometimes, surgery may also be used for recurrent disease. If the cancer comes back in one specific area and can be completely removed, surgery may offer a chance to control the disease again. In some patients with recurrent endometrial stromal sarcoma, doctors have reported long survival even after multiple surgical procedures to remove new tumors.^[20]

Hormone Therapy: A Key Tool for Many Patients

Unlike many other cancers, endometrial stromal sarcoma often responds well to hormone therapy. This type of treatment works because many endometrial stromal sarcoma cells have receptors for estrogen and progesterone. These receptors are like docking stations on the cell surface that hormones can attach to. When hormones attach, they can signal the cancer cells to grow. Hormone therapy blocks these signals or reduces hormone levels in the body.^[21]

One common type of hormone therapy uses medicines called progestins. These include megestrol acetate and medroxyprogesterone. Progestins are similar to the hormone progesterone and work against the effects of estrogen. They are typically given as pills that patients take every day. These medicines can help shrink tumors or slow their growth, especially in low-grade endometrial stromal sarcoma.^[21]

Another group of medicines used for hormone therapy are aromatase inhibitors. These drugs include letrozole, anastrozole, and exemestane. They work by blocking an enzyme called aromatase, which is responsible for making estrogen in fatty tissues. Aromatase inhibitors are most useful in patients who have gone through menopause or who have had their ovaries removed, since those are the situations where fatty tissue becomes the main source of estrogen. Like progestins, aromatase inhibitors are taken as daily pills.^[21]

For women who have not yet reached menopause and still have their ovaries, doctors may use gonadotropin-releasing hormone agonists. These medicines, such as goserelin and leuprolide, lower estrogen levels by affecting the signals between the brain and the ovaries. They are given as injections, usually every one to three months. By reducing estrogen production, these drugs create a hormonal environment less favorable to cancer growth.^[21]

Hormone therapy is often used after surgery to reduce the risk of the cancer returning. This is called adjuvant hormone therapy. It may also be used when the cancer has spread or when surgery is not possible. Studies have shown that hormone therapy can be effective in preventing recurrences and controlling disease. In one review, disease control was achieved in more than 70% of cases when hormone therapy was used for recurrent disease.^[6]

Side effects of hormone therapy can vary depending on which medicine is used. Many of the side effects resemble menopause symptoms. These can include hot flashes, night sweats, vaginal dryness, and mood changes. Some patients also experience increased appetite and weight gain. Fluid retention, causing swelling in the legs or hands, can occur. Joint or muscle pain is another possible side effect. In rare cases, progestins can increase the risk of blood clots. Long-term use of certain hormone therapies may weaken bones, leading to osteoporosis.^[21]

The good news is that many side effects can be managed. Your medical team can suggest ways to reduce symptoms and monitor for complications. Because hormone therapy is often taken for extended periods, finding ways to manage side effects is important for maintaining quality of life.^[21]

Radiation Therapy: Targeting Cancer with Precision

Radiation therapy uses high-energy beams to kill cancer cells. In endometrial stromal sarcoma, radiation may be used in several different situations. After surgery, doctors may recommend radiation to the pelvis to reduce the risk of the cancer coming back in that area. This is particularly considered for patients with high-grade disease or when the cancer had spread beyond the uterus but was surgically removed.^[8]

Radiation can also be used to treat specific areas where the cancer has recurred. If imaging shows a tumor in a particular spot, focused radiation can be delivered to that area. This approach can help control symptoms like pain and may slow the growth of the tumor. Some patients may receive newer forms of radiation, such as proton beam therapy, which delivers radiation more precisely to the tumor while sparing surrounding healthy tissue.^[16]

The side effects of radiation depend on which part of the body is treated and how much radiation is given. When the pelvis is treated, side effects may include fatigue, skin changes in the treated area, diarrhea, and bladder irritation. Most of these side effects are temporary and improve after treatment ends. However, some patients may experience long-term effects, such as bowel or bladder changes.^[8]

Chemotherapy: When Traditional Drugs Are Needed

Chemotherapy uses drugs to kill rapidly dividing cells, including cancer cells. Unlike hormone therapy, which is often the first choice for endometrial stromal sarcoma, chemotherapy is typically reserved for specific situations. It is most commonly used for high-grade endometrial stromal sarcoma, which tends to be more aggressive and less responsive to hormone therapy.^[8]

Chemotherapy may also be used when the cancer has spread to distant parts of the body, when it has recurred after other treatments, or when hormone therapy is no longer working. The specific chemotherapy drugs chosen depend on the individual case. Common regimens used for uterine sarcomas include combinations of drugs that have shown activity against these cancers.^[8]

In one case report, a patient with high-grade endometrial stromal sarcoma received chemotherapy combined with a newer targeted drug called apatinib. This combination approach showed promising results, with good disease control. After the initial treatment, the patient continued on apatinib alone as maintenance therapy. This type of approach, combining chemotherapy with targeted therapy, represents a potential new strategy for treating aggressive forms of endometrial stromal sarcoma.^[9]

Chemotherapy side effects can be significant and vary depending on which drugs are used. Common side effects include nausea, vomiting, hair loss, fatigue, and increased risk of infection due to low white blood cell counts. Some chemotherapy drugs can affect the heart, kidneys, or nerves. Your medical team will monitor you closely during treatment and can provide medicines and supportive care to help manage side effects.^[16]

Promising Approaches in Clinical Trials

Because endometrial stromal sarcoma is so rare, much of what we know about it comes from small studies and individual case reports. This also means that treatment options continue to evolve as researchers learn more. Clinical trials play a vital role in testing new approaches that might become standard treatments in the future.^[11]

One area of active research involves targeted therapies. These are drugs designed to attack specific molecular features of cancer cells while causing less harm to normal cells. For example, the drug apatinib is a small-molecule drug that blocks blood vessel formation around tumors. By cutting off the tumor’s blood supply, it can slow or stop cancer growth. Apatinib has been studied primarily in other types of cancers, but case reports suggest it may also benefit patients with endometrial stromal sarcoma, particularly high-grade disease.^[9]

Scientists are also investigating the genetic changes that drive endometrial stromal sarcoma. Many low-grade tumors have a specific genetic alteration called a chromosomal translocation. This involves two pieces of DNA from different chromosomes swapping places. In endometrial stromal sarcoma, a common translocation involves chromosomes 7 and 17. Understanding these genetic changes may help researchers develop drugs that specifically target the abnormal proteins produced by these alterations.^[6]

Another promising area involves immunotherapy. This type of treatment helps the body’s own immune system recognize and attack cancer cells. While immunotherapy has shown dramatic success in some cancers, its role in endometrial stromal sarcoma is still being explored. Researchers are testing whether certain patients with specific tumor characteristics might benefit from this approach.^[11]

Clinical trials for uterine sarcomas are conducted in specialized cancer centers around the world, including in the United States, Europe, and other regions. Because endometrial stromal sarcoma is rare, some trials group different types of uterine sarcomas together. Others focus specifically on endometrial stromal sarcoma or even on low-grade versus high-grade disease. Patients interested in clinical trials should discuss with their oncologist whether any trials are available and appropriate for their situation.^[12]

Clinical trials typically progress through phases. Phase I trials test whether a new drug is safe and help determine the right dose. Phase II trials look at whether the drug has an effect on the cancer. Phase III trials compare the new treatment to the current standard treatment to see if it works better. Each phase provides important information that moves the field forward.^[11]

Most common treatment methods

• Surgery
  • Total hysterectomy, which involves removing the uterus and cervix, is the primary surgical approach for most patients with endometrial stromal sarcoma.^[1]
  • Bilateral salpingo-oophorectomy, the removal of both ovaries and fallopian tubes, is often performed to reduce hormone levels that can fuel cancer growth.^[6]
  • Surgical removal of recurrent tumors may be performed when the disease returns in a location that can be completely resected.^[20]
  • Lymph node removal may be considered in some cases, though its routine use remains debated among specialists.^[6]
• Hormone therapy
  • Progestins such as megestrol acetate and medroxyprogesterone work against estrogen effects and are taken daily as pills.^[21]
  • Aromatase inhibitors including letrozole, anastrozole, and exemestane block estrogen production in fatty tissue and are used especially after menopause.^[21]
  • Gonadotropin-releasing hormone agonists like goserelin and leuprolide lower estrogen levels in premenopausal women and are given as injections.^[21]
  • Hormone therapy can be used after surgery to prevent recurrence or to treat cancer that has spread or returned.^[6]
• Radiation therapy
  • Pelvic radiation may be given after surgery to reduce the risk of local recurrence, particularly in high-grade disease.^[8]
  • Targeted radiation can be used to treat specific areas where cancer has recurred, helping control symptoms and slow tumor growth.^[8]
  • Proton beam therapy offers more precise radiation delivery, potentially reducing damage to surrounding healthy tissues.^[16]
• Chemotherapy
  • Chemotherapy is primarily used for high-grade endometrial stromal sarcoma or when hormone therapy is not effective.^[8]
  • Various drug combinations are used based on individual patient characteristics and disease behavior.^[8]
  • Chemotherapy may be combined with targeted drugs like apatinib in research settings for better disease control.^[9]
• Targeted therapy (in clinical trials)
  • Apatinib is a small-molecule drug that blocks blood vessel formation around tumors and has shown promise in case reports of high-grade disease.^[9]
  • Researchers are investigating drugs that target specific genetic changes found in endometrial stromal sarcoma cells.^[6]
  • Immunotherapy approaches are being explored to help the immune system recognize and fight cancer cells.^[11]

Living With Treatment: Follow-Up and Monitoring

After initial treatment, regular follow-up is essential. Endometrial stromal sarcoma, particularly the low-grade type, has a tendency to recur even many years after treatment. In fact, recurrences can happen 10, 15, or even 20 years later. This means that long-term monitoring is necessary for all patients.^[6]

Follow-up typically includes regular physical examinations and imaging tests. These might include CT scans, MRI scans, or ultrasound examinations. The frequency of these tests depends on the original stage and grade of the disease. Patients with high-grade disease or more advanced stages may need more frequent monitoring, especially in the first few years after treatment.^[15]

If cancer does recur, treatment options depend on where it has come back and what treatments were used previously. Surgery may be an option if the recurrence is in one area. Hormone therapy is often effective for recurrent low-grade disease. For high-grade recurrences or when other treatments have failed, chemotherapy or participation in a clinical trial may be considered.^[20]

It’s important for patients to report any new symptoms to their doctor right away. These might include unusual bleeding, pelvic pain, difficulty breathing, or abdominal swelling. Early detection of recurrence can sometimes provide more treatment options.^[1]

The Emotional Journey and Support

Dealing with a rare cancer diagnosis brings unique emotional challenges. Many patients feel isolated because few people understand what they’re going through. Finding support, whether through counseling, support groups, or online communities, can make a significant difference. Some cancer centers offer specific programs for patients with rare cancers.^[14]

The uncertainty of living with a cancer that can recur years later adds to the emotional burden. Some patients find it helpful to focus on what they can control, such as maintaining a healthy lifestyle, attending all follow-up appointments, and staying informed about their disease. Others benefit from mindfulness practices, therapy, or spiritual support.^[14]

Family members and caregivers also need support. They often carry their own worries while trying to support their loved one. Many cancer centers offer resources specifically for caregivers, including counseling and practical assistance.^[14]

Looking Forward

Advances in understanding endometrial stromal sarcoma continue. Researchers are identifying the molecular characteristics that make each patient’s cancer unique. This knowledge is leading to more personalized treatment approaches. As more patients participate in registries and clinical trials, the medical community learns more about what treatments work best.^[13]

Survival outcomes have improved over time, particularly for low-grade disease. Many patients live for many years after diagnosis, even if the cancer recurs. With appropriate treatment and monitoring, maintaining quality of life is possible for extended periods. For high-grade disease, treatment remains more challenging, but ongoing research offers hope for better options in the future.^[6]